Biochemical Reagent
-
BA6660 AZD7325Summary: AZD7325 is a positive allosteric modulator with oral activity of 0.3and1.3nM, respectively, but is less effective at α1 and α5 receptor subtypes. -
BA6661 EtifoxineSummary: Etifoxine is a non-benzodiazepine, GABAergic compound that is a positive modifier of the receptor subunits α1β2γ2 and α1β3γ2. - BA6662 AfloqualoneSummary: Afloqualone (HQ-495) is a GABAergic reagent with agonist activity on the β-subtype of the
- BA6663 PF-06372865Summary: PF-06372865 is an orally active, alpha2/alpha3/alpha5 subtype-selective positive alteration modulator (PAM).
- BA6665 MiltironeSummary: Miltirone is a natural product in existence.
- BA6666 MRK-016Summary: MRK-016 is a selective, orally available, antagonist that crosses the blood-brain barrier.
- BA6667 KavainSummary: Kavain is a class of kavalactones with anxiolytic effects in animals and humans.
- BA6668 TPA-023BSummary: TPA-023B is a high affinity orally active receptor subtype (as 0.73nM/2nM) partial agonist and subtype (as 1.8nM) antagonist.
- BA6669 BPDBASummary: BPDBA is a selective and noncompetitive inhibitor of the betaine/GABA transporter.
- BA6670 CirsimaritinSummary: Cirsimaritin weakly targets the benzodiazepine site on the binding receptor.